Paige specializes in the development of digital pathology platforms and generative AI applications within the healthcare sector. The company offers a cloud-based platform that enhances pathologists' workflow, increases diagnostic confidence and productivity, and provides AI-driven precision in cancer diagnosis. Paige's technology also aids pharmaceutical companies in evaluating treatment options and designing new biomarkers for drug development. It was founded in 2017 and is based in New York, New York.

4D Path specializes in cancer diagnostics using a patented platform that leverages statistical physics and tumor biology. The company offers an end-to-end automated platform for biomarker typing and prognostication from H&E images, serving pathologists, oncologists, and patients. Its cloud-based, quantitative approach aims to streamline precision oncology by providing biomarker profiling and stratification from biopsy or resection images, potentially reducing the need for additional molecular tests. It was founded in 2016 and is based in Newton Center, Massachusetts.

Mechanomind specializes in AI diagnostics within the healthcare sector, focusing on the detection and analysis of skin cancer. The company offers a suite of services that leverage computer vision and deep learning to analyze histopathology images for accurate skin cancer diagnosis. Mechanomind's technology is designed to be compatible with various modern scanning equipment, ensuring broad applicability and integration with existing digital pathology systems. It was founded in 2015 and is based in New York, New York.

TRIBVN Healthcare is a company focused on the digital transformation of cancer diagnosis within the healthcare sector. The company offers innovative solutions for the management, analysis, and sharing of cellular images, leveraging artificial intelligence technologies to support diagnostic decision-making and scientific evaluation. Its primary customers include diagnostic laboratories, pharmaceutical companies, and biotech organizations. It was founded in 2011 and is based in Paris, France.

Qritive focuses on driving diagnostics through artificial intelligence within the healthcare sector. The company develops clinical-grade AI-powered solutions designed to support pathologists by digitizing the entire pathology workflow, enhancing diagnosis accuracy, and enabling remote diagnosis and telepathology. It primarily serves the healthcare sector. The company was founded in 2017 and is based in Singapore.

Proscia focuses on the development of software for the pathology sector. The company offers include a digital pathology platform and artificial intelligence (AI) powered applications to facilitate routine pathology operations, research breakthroughs, and patient outcomes. Proscia primarily serves the life sciences and diagnostics sectors. It was founded in 2014 and is based in Philadelphia, Pennsylvania.